Menu
Not yet recruiting NCT07666737

The Effect of Pericapsular Nerve Group Block With Different Local Anesthetic Volumes

No phase Interventional Pericapsuler Nerve Group Block Postoperative Pain

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: pericapsular nerve group (PENG) block.
Who it may be relevant to
Registry conditions: Pericapsuler Nerve Group Block, Postoperative Pain. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Effect of Pericapsular Nerve Group Block With Different Local Anesthetic Volumes on Postoperative Pain in Arthroscopic Shoulder Surgery

Overview

Early postoperative pain following shoulder surgery is a significant clinical problem for both patients and orthopedic surgeons. Effective pain control is crucial for improving postoperative comfort and optimizing rehabilitation. Pericapsular nerve group block (PENG) is a regional anesthesia method that has recently gained attention due to its lack of motor block and absence of pulmonary complications. The aim of this study is to evaluate the effect of PENG block, applied at two different volumes, on postoperative pain and opioid consumption in patients undergoing arthroscopic shoulder surgery.

Interventions

  • Procedure pericapsular nerve group (PENG) block
    During PENG block application; the patient's arm was rotated externally and abducted at 45 degrees. A longitudinal linear ultrasound probe was placed between the coracoid and humeral head. After identifying the humeral head, the tendon of the subscapular muscle, and the deltoid muscle above it, a 50 mm needle was inserted using the "in-plane" technique. After the needle tip was placed above the bone below the subscapularis tendon, a local anesthetic solution was injected.

Primary outcome measures

  • postoperative pain and opiod consumption [Time frame: postoperative 24 hours]

Eligibility criteria

Inclusion criteria

  • elective arthroscopic shoulder surgery planned
  • ASA I-III physical status

Exclusion Criteria: Patients with

  • coagulopathy,
  • neuropathy,
  • anticoagulant use
  • history of chronic pain,
  • pre-existing psychiatric illness
  • body mass index greater than 35 kg/m2
  • allergy or sensitivity to local anesthetics and opiods
  • infection at the injection site
  • who cannot understand pain scoring
  • whose follow-up and treatment are continuing in the intensive care unit
  • who will undergo open shoulder surgery.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Supportive care

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07666737 · Pericapsular Nerve Group Block

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗